Back to Search
ELIZABETH PEREZ, M.D.
M.D.
Family Medicine Physician
NPI: 1316232796IndividualAccepts Medicare
Specialties, Licenses & Credentials
Family Medicine PhysicianPrimary
Family Medicine
Code: 207Q00000X
036142417(IL)A126085(CA)
CMS Specialties
PrimaryFAMILY PRACTICE
Education
OTHER
Class of 2011
Research & Publications (20)
N0332 phase 2 trial of weekly irinotecan hydrochloride and docetaxel in refractory metastatic breast cancer: a North Central Cancer Treatment Group (NCCTG) Trial.
PMID 19625343·Ann Oncol·2010
3-trial
Malignant pancreatic tumors: incidence and outcome in 58 pediatric patients.
PMID 19159743·J Pediatr Surg·2009
8-other
Impact, mechanisms, and novel chemotherapy strategies for overcoming resistance to anthracyclines and taxanes in metastatic breast cancer.
PMID 18443902·Breast Cancer Res Treat·2009
6-review
Microtubule inhibitors: Differentiating tubulin-inhibiting agents based on mechanisms of action, clinical activity, and resistance.
PMID 19671735·Mol Cancer Ther·2009
6-review
Cardiac toxicity of ErbB2-targeted therapies: what do we know?
PMID 18777950·Clin Breast Cancer·2008
6-review
Establishment of HIV-1 resistance in CD4+ T cells by genome editing using zinc-finger nucleases.
PMID 18587387·Nat Biotechnol·2008
7-preclinical
Cardiac safety analysis of doxorubicin and cyclophosphamide followed by paclitaxel with or without trastuzumab in the North Central Cancer Treatment Group N9831 adjuvant breast cancer trial.
PMID 18250349·J Clin Oncol·2008
3-trial
Premenopausal endocrine-responsive early breast cancer: who receives chemotherapy?
PMID 18325918·Ann Oncol·2008
8-other
Cardiac safety of lapatinib: pooled analysis of 3689 patients enrolled in clinical trials.
PMID 18533085·Mayo Clin Proc·2008
8-other
Safety profiles of tamoxifen and the aromatase inhibitors in adjuvant therapy of hormone-responsive early breast cancer.
PMID 17890211·Ann Oncol·2007
6-review
Safety of aromatase inhibitors in the adjuvant setting.
PMID 17912638·Breast Cancer Res Treat·2007
4-observational
Efficacy and safety of ixabepilone (BMS-247550) in a phase II study of patients with advanced breast cancer resistant to an anthracycline, a taxane, and capecitabine.
PMID 17606974·J Clin Oncol·2007
3-trial
Is there a gluteus medius tendon injury during reaming through a modified medial trochanteric portal? A cadaver study.
PMID 17921836·J Orthop Trauma·2007
8-other
Retroperitoneal and truncal sarcomas: prognosis depends upon type not location.
PMID 17206483·Ann Surg Oncol·2007
8-other
7201 carcinoids: increasing incidence overall and disproportionate mortality in the elderly.
PMID 17429568·World J Surg·2007
8-other
HER2 testing by local, central, and reference laboratories in specimens from the North Central Cancer Treatment Group N9831 intergroup adjuvant trial.
PMID 16809727·J Clin Oncol·2006
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 199 W RAND RD
MOUNT PROSPECT, IL 60056 - Phone
- (847) 618-5400
Quick Facts
- NPI
- 1316232796
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 15
- Publications
- 20
Are you this provider?
Claim Your Profile